Evidence map›Paper›PMID 27178003›Full record

ArticleBiopolymers2016

Efficient recombinant expression of SFTI-1 in bacterial cells using intein-mediated protein trans-splicing.

Yilong Li, Teshome Aboye, Leonard Breindel, Alexander Shekhtman, Julio A Camarero

Open access · greenAbstract read
In one paragraph

Article in Biopolymers, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Biotechnological Applications of Protein Splicing.Current protein & peptide science · 2019
    Review
  9. Article
  10. Article
  11. Cyclotides: Overview and Biotechnological Applications.Chembiochem : a European journal of chemical biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yilong LiDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, 90089-9121.
Teshome AboyeDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, 90089-9121.
Leonard BreindelDepartment of Chemistry, State University of New York, Albany, NY, 12222.
Alexander ShekhtmanDepartment of Chemistry, State University of New York, Albany, NY, 12222.
Julio A CamareroDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, 90089-9121.
University of Southern California · USUniversity at Albany, State University of New York · US

Funding

Real Time (RT) In-cell NMR technology to study protein interactions in live cellsR01GM085006 · NIGMS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI SHEKHTMAN, ALEXANDER · 2010 to 2021
$2.4M
Cell-based screening and selection of cyclotide-based capture reagents for proteiR01GM090323 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CAMARERO, JULIO A · 2009 to 2013
$2.0M
Screening and selection of specific protein-protein antagonists using ultrastable microprotein scaffoldsR01GM113636 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CAMARERO, JULIO A · 2015 to 2018
$1.3M
NIGMS NIH HHS R01 GM085006NIGMS NIH HHS R01 GM090323NIGMS NIH HHS R01 GM113636
6 · The paper itself

Abstract

We report for the first time the recombinant expression of bioactive wild-type sunflower trypsin inhibitor 1 (SFTI-1) inside E. coli cells by making use of intracellular protein trans-splicing in combination with a high efficient split-intein. SFTI-1 is a small backbone-cyclized polypeptide with a single disulfide bridge and potent trypsin inhibitory activity. Recombinantly produced SFTI-1 was fully characterized by NMR and was observed to actively inhibit trypsin. The in-cell expression of SFTI-1 was very efficient reaching intracellular concentration ≈ 40 µM. This study clearly demonstrates the possibility of generating genetically encoded SFTI-based peptide libraries in live E. coli cells, and is a critical first step for developing in-cell screening and directed evolution technologies using the cyclic peptide SFTI-1 as a molecular scaffold. © 2016 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 106: 818-824, 2016.

Indexed as

Gene ExpressionHelianthusInteinsPeptides, CyclicProtein SplicingEscherichia coliRecombinant ProteinsPeptides, CyclicRecombinant ProteinsSFTI-1 peptide, sunflowerbackbone-cyclized peptidesBowman-Birk inhibitorprotein splicingsplit-inteinsunflower trypsin inhibitor

Identifiers

PMID27178003
PMCPMC5108698
OpenAlexW2355539392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.